Neurotransmitter Changes in Alzheimer-Type Dementia and Therapeutic Strategies
Part of the Advances in Behavioral Biology book series (ABBI, volume 38A)
Neurotransmitter changes are one of the most important data when we think about the pathogenesis of Alzheimer-type dementia (ATD) and therapeutic strategies for ATD.
KeywordsControl Brain Cholinergic Drug Hybridization Histochemistry Neurotransmitter Change Hyperactive Condition
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 1.P. Davies and A.J. Maloney, Selective loss of central cholinergic neurons in Alzheimer’s disease, Lancet. ii: 1431 (1976).Google Scholar
- 5.H. Arai, P.C. Emson, S. Agrawal, C. Christodoulou, and M.J. Gait, In situ hybridization histochemistry:localization of vasopressin mRNA in rat brain using a biotinylated oligonucleotide probe, Mol. Brain Res. 4: 63–69 (1988).Google Scholar
© Plenum Press, New York 1990